Laboratory Test Directory

UTMB Google.com

Alphabetical Index

Search the Test Directory

Hours and Location

Specimen Collection

Antimicrobial Susceptibility Profile

Critical Values

AMCOM Paging Instructions

AMCOM Paging System

Phlebotomy Services

Normal Ranges

Laboratory Fee Schedule

Porphyria Shipping Instructions (New)

Therapeutic Guidelines

Heparin Therapy

Oral Anticoagulant therapy

Transfusion Criteria

 

Client Services

Laboratory Accreditation

Medicare & HIPAA Compliance

HUMAN IMMUNODEFICIENCY VIRUS I/II ANTIBODY (087-7204)

Test Mnemonic:

 HIV

Methodology:

 Screen - automated EIA (OCD 3600); confirmation - Western Blot (BioRad)

Performed:

  Clinical Chemistry

Turnaround Time:

 Routine: 8 hours, ASAP: 4 hours; confirmation of positives requires 3 - 7 days.

Specimen Requirements: Test Includes: Samples are screened for antibodies to HIV-I and HIV-II. If the screening test is reactive, a confirmation test (Western blot) is performed for HIV-I and HIV-II, as appropriate.

Collect:  7 mL of blood in SST (serum separator tube). (Min.: 3mL of blood). 

Specimen Preparation: Allow specimen to clot completely at room temperature. Centrifuge to separate serum from cells within 2 hours of collection. Transfer serum from collection tube to labeled plastic transport tube.  

Storage/Transport:  Delivered to Sample Management within 2 hours of collection.   

Stability:   Room temperature for ≤ 8 hours , refrigerated    for ≤ 48 hours, or  frozen if longer

Causes for Rejection:  Specimens containing particulate matter, specimens containing sodium azide, heat-inactivated specimens, bacterial contamination ,incomplete request/consent forms, incomplete and/or incorrect sample identification, improper storage/transport, and gross hemolysis and lipemia, gross hemolysis, leaking container,
Clinical Information:

If applicable, state clinical information that is required to be provided with specimen.

Reference Range:

By report (reports may vary based on instrumentation, patient age and sex)

Note:

 A consent form signed by patient, witness, and ordering physician must be completed for each specimen for inpatient testing and placed in the patient's chart. For non-UTMB patients, the physician is responsible for obtaining written consent and performing appropriate counseling for the test. To ensure irrefutable identification, the laboratory strongly recommends that the original collection tube be submitted to the laboratory for this test.

HIV-I confirmation (Western blot) results: The results are reported as: "Confirmed positive for the presence of HIV-I antibodies. Evidence of infection.", or " WB failed to confirm the presence of HIV-1 antibodies. Retest in 12 weeks if clinically indicated", or "WB is indeterminate, if this is the first test, testing should be repeated within 6-8 weeks if clinically indicated. If repeatedly indeterminate, retesting is not necessary unless warranted based on clinical circumstances." The interpretation is based on the band pattern exhibited in the test. The CDC recommendations are bands at any of the two following locations be considered positive: p24, gp41, gp120/160. The report will contain the positive bands and the interpretation.

CPT 4 Code:

 86703, 86689 (confirmation)

  Reviewed by Tho Nguyen, MT(ASCP) 7/11/13

When ordering tests for which Medicare or Medicaid reimbursement will be sought, physicians should only order tests that are medically necessary for the diagnosis or treatment of the patient.  Components of the organ or disease panels may be ordered individually.  The diagnostic information must substantiate all tests ordered and must be in the form of an ICD-9 code or its verbal equivalent.

 

  Home  |  Health Care  |  Education  |  Research  |  Business  |  News  |  Contribute  |  Alumni  |  About  |  Contact

©Copyright 2011 UTMB Health, Pathology Clinical Services. Please Review Our Site Policies & Required Links.
301 University Boulevard, Galveston, Texas, 77555-0743  • 
UTMB Maps & Directions


Member, Texas Medical Center®